| Literature DB >> 29950656 |
Victor González-Menéndez1, Gloria Crespo2, Nuria de Pedro2, Caridad Diaz2, Jesús Martín2, Rachel Serrano2, Thomas A Mackenzie2, Carlos Justicia2, M Reyes González-Tejero3, M Casares3, Francisca Vicente2, Fernando Reyes2, José R Tormo2, Olga Genilloud2.
Abstract
Native plant communities from arid areas present distinctive characteristics to survive in extreme conditions. The large number of poorly studied endemic plants represents a unique potential source for the discovery of novel fungal symbionts as well as host-specific endophytes not yet described. The addition of adsorptive polymeric resins in fungal fermentations has been seen to promote the production of new secondary metabolites and is a tool used consistently to generate new compounds with potential biological activities. A total of 349 fungal strains isolated from 63 selected plant species from arid ecosystems located in the southeast of the Iberian Peninsula, were characterized morphologically as well as based on their ITS/28S ribosomal gene sequences. The fungal community isolated was distributed among 19 orders including Basidiomycetes and Ascomycetes, being Pleosporales the most abundant order. In total, 107 different genera were identified being Neocamarosporium the genus most frequently isolated from these plants, followed by Preussia and Alternaria. Strains were grown in four different media in presence and absence of selected resins to promote chemical diversity generation of new secondary metabolites. Fermentation extracts were evaluated, looking for new antifungal activities against plant and human fungal pathogens, as well as, cytotoxic activities against the human liver cancer cell line HepG2. From the 349 isolates tested, 126 (36%) exhibited significant bioactivities including 58 strains with exclusive antifungal properties and 33 strains with exclusive activity against the HepG2 hepatocellular carcinoma cell line. After LCMS analysis, 68 known bioactive secondary metabolites could be identified as produced by 96 strains, and 12 likely unknown compounds were found in a subset of 14 fungal endophytes. The chemical profiles of the differential expression of induced activities were compared. As proof of concept, ten active secondary metabolites only produced in the presence of resins were purified and identified. The structures of three of these compounds were new and herein are elucidated.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29950656 PMCID: PMC6021435 DOI: 10.1038/s41598-018-28192-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Consensus tree from Bayesian-phylogeny inferences based on ITS/28S sequences of almost all isolated genera within Pleosporales order and related genera. Clade probability values/maximum likelihood bootstrap values are indicated respectively on the branches. Values < 50 are designated by “−”. Cryptococcus sp. CF-285748 was used as an outgroup.
Figure 2Activity distribution of isolates according to the fermentation conditions on each of the assays: (i) hits induced by adsorptive resins (orange), (ii) hits only produced without resins (blue) or (iii) hits produced in both conditions (green).
Figure 3Distribution of dereplicated known fungal compounds in active isolates according to the fermentation condition of the producers. (i) Compounds detected in the presence of adsorptive resins (orange), (ii) compounds only produced without resins (blue) and (iii) compounds produced in both conditions (green).
Characterization of tentative new secondary metabolites by HPLC-ESI-TOF-MS.
| Strain | RT (min) | [M + H]+ Exp. | Proposed Ion | Main Secondary Experimental Ions | Production Media | Proposed Formula | Compound |
|---|---|---|---|---|---|---|---|
| CF-285754 | 3.91 | 497.11 | C22H25O11S+ | 498.1138; 183.1372; 295.2259 | LSFM + XAD16 | C22H24O11S | A |
| CF-285755 | 3.92 | 497.1104 | C22H25O11S+ | 498.1138; 271.0587; 183.1217 | LSFM + XAD16 | C22H24O11S | |
| CF-285753 | 3.91 | 497.1102 | C22H25O11S+ | 498.1135; 499.1105; 519.0918 | LSFM + XAD16 | C22H24O11S | |
| CF-288957 | 5.04 | 656.3848 | C30H55O14+ | 657.3879; 658.39 | YES & HP20 | C30H54O14 | B |
| CF-090351 | 5.01 | 656.3852 | C30H55O14+ | 657.3885; 658.3911 | MMK2 & XAD16 | C30H54O14 | |
| CF-091924 | 5.33 | 933.5659 | C46H74N7O12+ | 916.5391; 458.7725; 934.5688 | YES & HP20 | C46H73N7O12 | C |
| CF-091924 | 5.49 | 947.5815 | C47H76N7O12+ | 930.5549; 948.5846; 931.5579 | YES & HP20 | C47H75N7O12 | D |
| CF-091924 | 6.11 | 914.5596 | C47H76N7O11+ | 457.7832; 931.5863; 932.5891 | YES & HP20 | C47H75N7O11 | E |
| CF-090782 | 5.08 | 328.2475 | C39H28NO8S+ | 293.2104; 329.2508; 275.1997 | MMK2 + XAD16 | C39H27NO8S | F |
| CF-288938 | 4.65 | 328.2471 | C39H28NO8S+ | 275.1994; 311.2206; 279.2308 | MMK2 | C39H27NO8S | |
| CF-287465 | 6.27 | 780.5469 | C40H75O13+ | 781.5503; 745.5095; 785.5019 | LSFM & XAD16 | C40H74O13 | G |
| CF-285758 | 4.85 | 415.1392 | C22H23O8+ | 416.1421; 359.1124; 301.0704 | YES + HP20 | C22H22O8 | H |
| CF-285760 | 2.61 | 521.2349 | C18H33N8O10+ | 522.2374; 538.2608; 523.2389 | MMK2 | C18H32N8O10 | I |
| CF-285773 | 2.54 | 521.2335 | C18H33N8O10+ | 522.2363; 539.2626; 523.239 | XPMK + HP20 | C18H32N8O10 | |
| CF-285765 | 5.54 | 551.1503 | C36H23O6+ | 568.1767; 552.1532; 559.1794 | YES | C36H22O6 | J |
| CF-090361 | 3.76 | 343.1926 | C18H31O4S+ | 235.2048; 344.1957; 943.5241 | LSFM& MMK2 | C18H30O4S | K |
| CF-090361 | 7.99 | 532.439 | C30H59O4S+ | 515.4127; 532.44226; 516.416 | LSFM & MMK2 | C30H58O4S | L |
Figure 4(A–D) Examples of the differential expression of antifungal agents induced by the presence of resins during the fermentation. Comparison of SMs profiles and identification of relevant components performed by LCMS.
Figure 5(A–D) Examples of the differential expression of cytotoxic agents induced by the presence of resins during fermentation. Comparison of SMs profiles and identification of relevant components performed by LCMS.
Figure 6Dose-response curves and ED50 (µM) for new compounds 1–3 against a diverse panel of human cancer cells lines.